News
Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...
1d
The Punch on MSNSickle cell disease and healthcare inequitiesSickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the ...
The condition mostly affects those from African and Caribbean backgrounds but Victoria Ekanoye says it can affect anyone. | ...
2d
GlobalData on MSNVertex reports long-term results for Casgevy in sickle cell and thalassaemiaVertex Pharmaceuticals’ Casgevy (exagamglogene autotemcel) has continued to show benefits in sickle cell disease (SCD) ...
Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.
Sickle Cell Disease Market Insight, Epidemiology And Market Forecast - 2034The sickle cell disease treatment market is experiencing signific ...
A study by the Centre for Policy Impact in Global Health revealed that over 30 per cent of people with SCD in Nigeria ...
A doctor says she’s scrambling to figure out how she’ll continue her work helping sickle cell disease patients after the ...
Sickle cell disease affects about 100,000 people in the U.S., and 90% of patients are Black, according to NIH.
A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...
Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...
From jaundice to swelling in hands, know the early signs of sickle cell disease. The doctor also shared when to seek medical intervention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results